Hims' Weight Loss Expansion: Real Growth or Just Hype?

Hims & Hers Health TodayHIMSHims & Hers Health$29.39 +3.29 (+12.62$11.20▼$72.98P/E Ratio66.80Price Target$38.75Add to WatchlistOne of the more hotly debated stocks in the market, Hims & Hers Health NYSE: HIMS, recently made an interesting announcement. The healthcare company said that it will now offer branded Zepbound, Eli Lilly’s NYSE: LLY blockbuster weight loss drug. Zepbound is the most effective weight loss drug that has been approved by the Food and Drug Administration (FDA).  Studie ...